Gelonghui November 2nd 丨Some investors asked Dongbao Biotech (300239.SZ) on the investor interactive platform, “Does your company have developed pharmaceuticals for diseases such as mammary glands, dermatitis, joints, epilepsy, tumors, cancer, genetic mitochondria, etc., as well as health care products such as weight loss drugs and fitness equipment”
The company said that the company's main products are gelatin, plasma gelatin, collagen, hollow capsules and TOC end series, which are widely used in downstream biomedicine, medicine, health products, functional foods, and beauty. The company does not produce pharmaceuticals, diet pills or fitness equipment.